Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 5
2005 1
2006 2
2008 3
2009 1
2010 2
2011 1
2012 2
2013 1
2014 1
2015 3
2016 2
2017 3
2018 4
2019 3
2020 5
2021 6
2022 9
2023 5
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean stephane prieto (1 results)?
Correspondence: serum neutralization of SARS-CoV-2 Omicron sublineages BA.1, BA.2 and BA.5 in lung transplant recipients receiving prophylactic tixagevimab/cilgavimab.
Eldin C, Nurtop E, Coiffard B, Colombini N, Ninove L, Priet S, Barthélémy K, Reynaud-Gaubert M, de Lamballerie X. Eldin C, et al. Among authors: priet s. Infection. 2024 Apr 7. doi: 10.1007/s15010-024-02258-1. Online ahead of print. Infection. 2024. PMID: 38584221 No abstract available.
Exploring cell-free assays for COVID-19 serosurvey.
Inchauste L, Nurtop E, Brisbarre N, Ninove L, Gallian P, de Lamballerie X, Priet S. Inchauste L, et al. Among authors: priet s. Sci Rep. 2024 Mar 13;14(1):6096. doi: 10.1038/s41598-024-55852-6. Sci Rep. 2024. PMID: 38480769 Free PMC article.
SARS-CoV-2 infection prevalence and associated factors among primary healthcare workers in France after the third COVID-19 wave.
Pouquet M, Decarreaux D, Di Domenico L, Sabbatini CE, Prévot-Monsacre P, Fourié T, Villarroel PMS, Priet S, Blanché H, Sebaoun JM, Deleuze JF, Turbelin C, Rossignol L, Werner A, Kochert F, Grosgogeat B, Rabiega P, Laupie J, Abraham N, Noël H, van der Werf S, Colizza V, Carrat F, Charrel R, de Lamballerie X, Blanchon T, Falchi A. Pouquet M, et al. Among authors: priet s. Sci Rep. 2024 Mar 5;14(1):5418. doi: 10.1038/s41598-024-55477-9. Sci Rep. 2024. PMID: 38443618 Free PMC article.
Association of SARS-CoV-2 infection with physical activity domains and types.
Vanhelst J, Srour B, Bourhis L, Charreire H, VerdotDeschasaux-Tanguy CM, Druesne-Pecollo N, de Edelenyi FS, Allègre J, Allès B, Deschamps V, Bellicha A, Fezeu LK, Galan P, Julia C, Kesse-Guyot E, Hercberg S, Bajos N, Severi G, Zins M, de Lamballerie X, Carrat F, Oppert JM, Touvier M; SAPRIS, SAPRIS-SERO Study Groups. Vanhelst J, et al. Sci Rep. 2023 Nov 6;13(1):19187. doi: 10.1038/s41598-023-46162-4. Sci Rep. 2023. PMID: 37932323 Free PMC article.
Metapopulation dynamics of SARS-CoV-2 transmission in a small-scale Amazonian society.
Kraft TS, Seabright E, Alami S, Jenness SM, Hooper P, Beheim B, Davis H, Cummings DK, Rodriguez DE, Cayuba MG, Miner E, de Lamballerie X, Inchauste L, Priet S, Trumble BC, Stieglitz J, Kaplan H, Gurven MD. Kraft TS, et al. Among authors: priet s. PLoS Biol. 2023 Aug 22;21(8):e3002108. doi: 10.1371/journal.pbio.3002108. eCollection 2023 Aug. PLoS Biol. 2023. PMID: 37607188 Free PMC article.
ABO blood types and SARS-CoV-2 infection assessed using seroprevalence data in a large population-based sample: the SAPRIS-SERO multi-cohort study.
Deschasaux-Tanguy M, Szabo de Edelenyi F, Druesne-Pecollo N, Esseddik Y, Allègre J, Srour B, Galan P, Hercberg S, Severi G, Zins M, Wiernik E; SAPRIS-SERO study group; de Lamballerie X, Carrat F, Touvier M. Deschasaux-Tanguy M, et al. Sci Rep. 2023 Mar 23;13(1):4775. doi: 10.1038/s41598-023-30714-9. Sci Rep. 2023. PMID: 36959255 Free PMC article. Clinical Trial.
Low to undetectable Omicron BQ.1.1 neutralization by patient's sera a month after initiation of AZD7442 600 mg.
Touret F, Martin-Blondel G, de Lamballerie X, Dupont A, Izopet J, Mentré F, Kamar N, Autran B, Paintaud G, Caillard S, Richez C, Couzi L, Xhaard A, Marjanovic Z, Avouac J, Jacquet C, Anglicheau D, Cheminant M, Yazdanpanah Y, N'Guyen S, Terrier B, Gottenberg JE, Besson C, Letrou S, Kali S, Angoulvant D, Barthélémy K, Priet S, Nurtop E, Sanchez VP, Tardivon C, Blancho G, Le Bourgeois A, Lévy V. Touret F, et al. Among authors: priet s. J Infect. 2023 May;86(5):e126-e129. doi: 10.1016/j.jinf.2023.02.002. Epub 2023 Feb 5. J Infect. 2023. PMID: 36750165 No abstract available.
Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years.
Durier C, Ninove L, Lefebvre M, Radenne A, Desaint C, Ropers J, Bauer R, Lebbah S, Carette D, Lachatre M, Lecompte AS, Deplanque D, Botelho-Nevers E, Conrad A, Dussol B, Maakaroun-Vermesse Z, Melica G, Nicolas JF, Verdon R, Kiladjian J, Loubet P, Schmidt-Mutter C, Dualé C, Ansart S, Priet S, Levier A, Molino D, Vieillard LV, Parfait B, Lelièvre JD, Tartour E, de Lamballerie X, Launay O; ANRS0002S CoviCompareP Group; AP-HP CoviCompareM Group; Biological resource centers; Laboratories; Trial coordination; Sponsor; Scientific Committee. Durier C, et al. Among authors: priet s. Sci Rep. 2022 Nov 27;12(1):20373. doi: 10.1038/s41598-022-24409-w. Sci Rep. 2022. PMID: 36437298 Free PMC article.
59 results